McKelvy Michael E
Known title: DirectorCIK: 0001426872
Associated companies
Transaction History
| AMRZ | ▼ Sell | Tax Withholding | 740 | $42K | 4/21/2026 | View on chart |
| AMRZ | ▲ Buy | Grant | 2,976 | $0 | 4/21/2026 | View on chart |
| AMRZ | ▲ Buy | Grant | 2,958 | $0 | 8/11/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
JP Morgan cuts Amrize price target to $48, maintains Neutral
JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.
JP Morgan cuts Amrize price target to $48, maintains Neutral. JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.